Early research (Phase 1)Study completedNCT02036918What this trial is testingDendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate CancerWho this might be right forProstate Cancer Duke University 20
Not applicableLooking for participantsNCT05378204What this trial is testingStudy Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.Who this might be right forBreast Cancer Institut Claudius Regaud 120
Early research (Phase 1)Looking for participantsNCT07543055What this trial is testingBPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has SpreadWho this might be right forProstate Cancer Regeneron Pharmaceuticals 36
Early research (Phase 1)Ended earlyNCT00933426What this trial is testingLenalidomide and Paclitaxel in Prostate CancerWho this might be right forProstate Cancer M.D. Anderson Cancer Center 17
Not applicableStudy completedNCT02813408What this trial is testingInvestigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer ParticipantsWho this might be right forProstatic Neoplasms Janssen Pharmaceutica N.V., Belgium 226
Early research (Phase 1)Study completedNCT01540526What this trial is testingPharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose AxitinibWho this might be right forSolid MalignanciesMetastatic Castrate-resistant Prostate Cancer University of Wisconsin, Madison 24
Large-scale testing (Phase 3)Study completedNCT02043678What this trial is testingRadium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild SymptomsWho this might be right forProstatic Neoplasms Bayer 806
Not applicableWithdrawnNCT03669692What this trial is testingOpen Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.Who this might be right forProstatic Hyperplasia, BenignMetabolic Syndrome Complexo Hospitalario Universitario de A Coruña
Not applicableUnknownNCT05078151What this trial is testingWhole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate CancerWho this might be right forProstate Cancer Metastatic Vall d'Hebron Institute of Oncology 69
Not applicableLooking for participantsNCT07677267What this trial is testingReal-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide TetraxetanWho this might be right forProstatic Neoplasms, Castration-Resistant Novartis Pharmaceuticals 1,067
Testing effectiveness (Phase 2)Looking for participantsNCT05489211What this trial is testingStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)Who this might be right forEndometrial CancerGastric CancerMetastatic Castration-resistant Prostate Cancer+4 more AstraZeneca 454
Not applicableEnded earlyNCT01073644What this trial is testingPost Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino PatientsWho this might be right forMetastatic Renal Cell Carcinoma Pfizer 3
Testing effectiveness (Phase 2)Ended earlyNCT03207867What this trial is testingNIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaWho this might be right forNSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more Novartis Pharmaceuticals 315
Testing effectiveness (Phase 2)Study completedNCT03093428What this trial is testingStudy Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPCWho this might be right forProstate Cancer Dana-Farber Cancer Institute 45
Not applicableStudy completedNCT07450157What this trial is testingPatient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617Who this might be right forProstate Cancer Novartis Pharmaceuticals 6,448
Testing effectiveness (Phase 2)Study completedNCT02121639What this trial is testingOpen Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP ChemotherapyWho this might be right forProstate Cancer University Hospital Southampton NHS Foundation Trust 160
Testing effectiveness (Phase 2)Ended earlyNCT05405439What this trial is testingTo Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 39
Not applicableLooking for participantsNCT06228677What this trial is testingComparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery EmbolizationWho this might be right forResistant HypertensionSecondary HypertensionSecondary Hypertension to Endocrine Disorders+1 more First Affiliated Hospital of Chengdu Medical College 196
Testing effectiveness (Phase 2)Study completedNCT01881867What this trial is testingCYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forCastration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+1 more Fred Hutchinson Cancer Center 54
Testing effectiveness (Phase 2)UnknownNCT04247256What this trial is testingTrial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRIWho this might be right forMetastatic Colorectal Cancer Scandion Oncology A/S 35